Literature DB >> 26969037

Pilot-scale cultivation of wall-deficient transgenic Chlamydomonas reinhardtii strains expressing recombinant proteins in the chloroplast.

Julie A Z Zedler1, Doris Gangl1, Tiago Guerra2, Edgar Santos2, Vitor V Verdelho2, Colin Robinson3.   

Abstract

Microalgae have emerged as potentially powerful platforms for the production of recombinant proteins and high-value products. Chlamydomonas reinhardtii is a potentially important host species due to the range of genetic tools that have been developed for this unicellular green alga. Transformation of the chloroplast genome offers important advantages over nuclear transformation, and a wide range of recombinant proteins have now been expressed in the chloroplasts of C. reinhardtii strains. This is often done in cell wall-deficient mutants that are easier to transform. However, only a single study has reported growth data for C. reinhardtii grown at pilot scale, and the growth of cell wall-deficient strains has not been reported at all. Here, we report the first pilot-scale growth study for transgenic, cell wall-deficient C. reinhardtii strains. Strains expressing a cytochrome P450 (CYP79A1) or bifunctional diterpene synthase (cis-abienol synthase, TPS4) were grown for 7 days under mixotrophic conditions in a Tris-acetate-phosphate medium. The strains reached dry cell weights of 0.3 g/L within 3-4 days with stable expression levels of the recombinant proteins during the whole upscaling process. The strains proved to be generally robust, despite the cell wall-deficient phenotype, but grew poorly under phototrophic conditions. The data indicate that cell wall-deficient strains may be highly amenable for transformation and suitable for commercial-scale operations under mixotrophic growth regimes.

Entities:  

Keywords:  CYP79A1; Cell wall-deficient; Chlamydomonas; Microalgae; Pilot scale; cis-abienol synthase

Mesh:

Substances:

Year:  2016        PMID: 26969037     DOI: 10.1007/s00253-016-7430-y

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

Review 1.  Emerging Trends in Genetic Engineering of Microalgae for Commercial Applications.

Authors:  Samir B Grama; Zhiyuan Liu; Jian Li
Journal:  Mar Drugs       Date:  2022-04-24       Impact factor: 6.085

Review 2.  Harnessing the Algal Chloroplast for Heterologous Protein Production.

Authors:  Edoardo Andrea Cutolo; Giulia Mandalà; Luca Dall'Osto; Roberto Bassi
Journal:  Microorganisms       Date:  2022-03-30

3.  High-yield secretion of recombinant proteins from the microalga Chlamydomonas reinhardtii.

Authors:  Erick Miguel Ramos-Martinez; Lorenzo Fimognari; Yumiko Sakuragi
Journal:  Plant Biotechnol J       Date:  2017-04-11       Impact factor: 9.803

4.  Human Intrinsic Factor Expression for Bioavailable Vitamin B12 Enrichment in Microalgae.

Authors:  Serena Lima; Conner L Webb; Evelyne Deery; Colin Robinson; Julie A Z Zedler
Journal:  Biology (Basel)       Date:  2018-02-19

5.  CITRIC: cold-inducible translational readthrough in the chloroplast of Chlamydomonas reinhardtii using a novel temperature-sensitive transfer RNA.

Authors:  Rosanna Young; Saul Purton
Journal:  Microb Cell Fact       Date:  2018-11-24       Impact factor: 5.328

Review 6.  A force awakens: exploiting solar energy beyond photosynthesis.

Authors:  David A Russo; Julie A Z Zedler; Poul Erik Jensen
Journal:  J Exp Bot       Date:  2019-03-27       Impact factor: 6.992

7.  Generation of microalga Chlamydomonas reinhardtii expressing shrimp antiviral dsRNA without supplementation of antibiotics.

Authors:  Patai Charoonnart; Nichakorn Worakajit; Julie A Z Zedler; Metha Meetam; Colin Robinson; Vanvimon Saksmerprome
Journal:  Sci Rep       Date:  2019-02-28       Impact factor: 4.379

8.  Downstream Processing of Chlamydomonas reinhardtii TN72 for Recombinant Protein Recovery.

Authors:  Laura Stoffels; Arran Finlan; Gareth Mannall; Saul Purton; Brenda Parker
Journal:  Front Bioeng Biotechnol       Date:  2019-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.